WO2008146250A2

WO2008146250A2 - Stess relief therapy

Info

Publication number: WO2008146250A2
Application number: PCT/IB2008/052099
Authority: WO
Inventors: Izak Johannes Grove
Original assignee: Izak Johannes Grove
Priority date: 2007-06-01
Filing date: 2008-05-29
Publication date: 2008-12-04
Also published as: WO2008146250A3

Abstract

A method of applying beneficial stimuli to a body of a person, the method including providing a partially sealed chamber around at least a portion of the body of a person and disposing a poly-atomic oxygen composition into the partially sealed chamber so as to expose the portion of the body to an increased concentration of the poly-atomic oxygen, subjecting the portion of the body to a dry heat source, and subjecting the potion of the body to a Rife frequency source.

Description

STRESS RELIEF THERAPY

This invention relates to stress relief therapy. More particularly, the invention relates to a method of applying beneficial stimuli to a body of a person and to a treatment device.

BACKGROUND OF THE INVENTION

The inventor is aware of stress relief methods including application of so called Rife frequencies named after Royal Raymond Rife born in 1888, which cause beneficial activity in organs and parts of the body. Furthermore the ability to destroy non-beneficial organisms with certain Rife frequencies is also known to the applicant. The inventor is further aware of light therapy and colour therapy and in particular Infra-Red (IR) and Ultra-Violet (UV) light radiation therapy which also causes beneficial reaction of the skin and other parts of the body when exposed to specific doses of specific light frequencies. The inventor is also aware of treatment methods where the body of a person is exposed to so called Ozone and in particular O³, as well as other Poly-Atomic Oxygen compositions. However, the methods and therapies in this field of technology are applied in isolation with each other and does not provide for a holistic approach to wellness. The present invention aims to address some of these shortcomings.

SUMMARY OF THE INVENTION

According to one aspect of the invention, there is provided a method of applying beneficial stimuli to a body of a person, the method including providing a partially sealed chamber around at least a portion of the body of a person and disposing a poly-atomic oxygen composition into the partially sealed chamber so as to expose the portion of the body to an increased concentration of the poly-atomic oxygen; subjecting the portion of the body to a dry heat source; and subjecting the potion of the body to a Rife frequency source.

The term dry heat source in this specification refers to a heat source that does not use steam to provide heat, such as heated dry air, an Infra-Red heat radiator, or the like.

The poly-atomic oxygen composition may be in the form of O³, also referred to as ozone.

The method may include spraying an atomized/nebulized liquid or mist onto the body of the person. The atomized liquid may be selected from any one of H₂O and H₂O₂.

The Rife frequency source may be in the form of any one of an electromagnetic wave generator, a pressure wave generator, and an electrical signal generator, all of which are operable to generate signals at the so called Rife frequencies. The Rife frequencies are well known in the literature and will not be discussed further in this specification.

The method may include the prior step of positioning the body of a person in a position which is beneficial to lymphatic circulation and blood circulation, such as a seated position or a lying position.

The Rife frequency source may be in the form of a Far Infra-Red (FIR) source. In particular, the far infra-red source may operate at a wavelength of between 2μm to 15μm. The inventor believes that any other medically safe heat source which does not inherently raise the humidity around the skin of the exposed body portion may provide beneficial results. Subjecting the portion of the body to a dry heat source may include subjecting the portion of the body to a heat source of between 4O⁰C to 7O⁰C. The inventor found that this temperature heats the body of a person without causing discomfort.

Subjecting the body of a person to an increased concentration of O³ while the body of a person is heated, has been found to be beneficial in terms of the detoxification of the body from stress causing chemical toxins and pathogens. It also enhances overall oxygenation of the body which helps stimulate normal functioning of the body.

The inventor found that the O³ is easily broken down into O² and H2O2 if it is exposed to a high humidity environment at a raised temperature. However, the inventor found that a temperature of between 4O⁰C to 7O⁰C at a low humidity allows the O³ to maintain its structure for at least 120 minutes. In particular, the inventor found that an O³ concentration of between 20ppm and 600ppm can be achieved after between 5 to 25 minutes at a temperature up to 7O⁰C in a low humidity environment as opposed to an O³ concentration of about 4ppm in a high humidity environment, after an application of O³ at a rate of one litre per minute into the chamber.

The method may include subjecting at least a portion of the body of a person to the O³, the dry heat and the Rife frequencies for a period of between 10 and 60 minutes, more particularly, for a period about 30 minutes.

The method may include the latter step of extracting the Oxygen/O³ from the chamber.

According to another aspect of the invention, there is provided a treatment device, which includes a chamber into which at least a portion of the body of a person can be positioned; heat generation means for heating the portion of the body of a person in the chamber;

Rife frequency delivery means operable to subject the body of a person to rife frequencies.

The chamber may include at least one gas port connectable to a supply of gas > ssuucchh aass O³, the gas port extending into the chamber for release of gas into the chamber.

The treatment device may include gas regulation means, such as gas valve, in communication with the gas port and a supply of gas, the regulation means operable to control the flow of gas from the supply of gas, via the gas port into the chamber.

The treatment device may include a controller, connectable to any one or more of the gas regulation means, the heat generation means and the Rife frequency delivery means, operable to control any one or more of the supply of gas via the gas regulation means, the heat generation means and the operation of the rife frequency generation means.

In one embodiment, the chamber may be in the form of a sealed enclosure shaped and dimensioned to receive the whole of a person's body. The enclosure may include an aperture through which the head of a person may protrude, in use. The enclosure may be shaped and dimensioned, in use, to receive a person in a seated position with an opening shaped and dimensioned to allow the neck of a person to protrude through it.

In another embodiment, the chamber may be in the form of an enclosure, shaped and dimensioned to receive only a portion of a person's body such as a foot, a leg, a hand, an arm, or the like. In yet another embodiment, the device may include a second chamber shaped and dimensioned to receive a portion of a person's body, or to be attachable to a person's body to define a zone of increased pressure, where the poly-atomic oxygen can be discharged on the skin of a person, in use.

The heat generation means may be disposed in the chamber, operable to generate heat in the chamber. The heat generation means may be in the form of any one of an air heater, a resistive element type heater, and an Infra Red (IR) source, operable to generate heat through illumination of the body of the person with electromagnetic waves in the Infra-Red electromagnetic band. The inventor found that electromagnetic waves in the far Infra-Red electromagnetic band produced beneficial results.

The heater may include electrically heatable ceramic tiles, operable to radiate a desired amount of Infra-Red radiation.

The heat generation means may include a heat regulator, operable upon selection by a user to regulate the temperature in the chamber to a pre-selected temperature.

The inside of the chamber may be provided with reflective material, in use to promote even distribution of Infra-Red radiation.

In this specification, the Rife frequency delivery means is intended to include electromagnetic wave generation means such as Light Emitting Diodes (LED's) and magnetic coils, sonic transducers such as ultra-sonic transducers and electrical contacts such as electrodes, which are operable to deliver a desired light frequency, a desired sonic frequency or electrical impulses at a desired frequency to a body of a person.

In one embodiment, the Rife frequency delivery means may be in the form of magnetic coils disposed proximate the body of a person. The treatment device may include a heart rate monitor interface, operable to measure the heart rate of a person.

In another embodiment, the Rife frequency delivery means may be in the form of electrical electrodes disposed in the chamber to be in contact with the body of a person, for example to be held by hand. In another embodiment, the electrodes may be positioned to be in contact with at least one foot of a person, or in contact with another body part as may be desired. The electrodes may be connectable to a heart rate monitor, operable when touched by a person to monitor the heart rate of the person.

The treatment device may include a blood oxygen meter operable to monitor the blood oxygen level in a person's blood.

The treatment device may include a toxin meter arranged to collect body fluids excreted through the skin of a person and to provide an indication of the composition of said fluids.

The invention will now be described, by way of example only with reference to the following drawings:

DRAWINGS

In the drawing(s):

Figure 1 shows a treatment device in accordance with the invention; Figure 2 shows the treatment device of Figure 1 in use; and Figure 3 shows a control panel of a controller of the treatment device of Figure 1.

EMBODIMENT OF THE INVENTION In Figure 1 , a treatment device 10 is shown. The treatment device 10 defines a chamber 12, into which a person can be seated. The chamber comprises a fixed seat portion 14 and two hingedly connectable wing doors 16, 18.

The fixed seat portion 14 and the doors 16, 18 are manufactured of a durable fibre glass material. The seat portion 14 is shaped and dimensioned to receive a person in a seated position (see Figure 2) so that the person is seated at a slight backwardly inclined position. The seating position of the person is such as to allow proper lymphatic and blood circulation levels.

Towards the bottom of the seated portion 14, a moulded drip tray 20 is provided. The seat portion 14 and the drip tray 20 are integrally moulded. Beneath the drip tray 20 a removable liquid collector 22 is provided, operable to receive and collect any liquids disposed onto the drip tray 20.

The two winged doors 16, 18 are provided with integrally formed arm rests 16.1 18.1 which, when the doors 16, 18 are closed, provide a comfortable resting place for the arms of a person seated on the seat portion 14. Furthermore, the arm rests 16.1 18.1 provide support to a user to enter and exit the chamber 12.

On the armrests Rife frequency delivery means in the form of two stainless-steel electrodes 16.2, 18.2 are provided, which can be held by a person when seated on the seat portion 14.

Eight gas inlet ports 24.1 to 24.8 are provided into the chamber 12, and are connected to gas regulation means in the form of a gas valve (not shown) which is connected to a supply (not shown) of O³ gas, in this example.

It is to be appreciated, in other embodiments, that the gas inlet ports may be located to optimise delivery of gas to the skin surface, such as for example in slots provided on the seat portion 14 of the chamber, or in other positions where gas delivery to the skin is required.

The top of the seat portion 14 is provided with an integral head rest 14.1 onto which a person can rest his head when seated on the seat portion 14.

Feet supports are provided (not shown) for supporting the feet of an individual to improve their comfort when seated in the chamber 12.

The stainless-steel electrodes 16.2, 18.2 are connectable to an electronic signal generator which is operable to generate electrical impulses in the frequency range of 0.1 Hz to 60 KHz. The electrical impulses are generated at a user adjustable peak-to-peak voltage of OV to 40V.

The electrodes 16.2, 18.2 are provided with integral heart rate monitor electrodes for picking up the heart rate of a person and transmitting the heart rate to a remote heart rate monitor (not shown).

The winged doors 16, 18 are connectable to the seat portion 14 by means of six hinges 26.1 to 26.6.

On each of the winged doors 16, 18 a Far Infra-Red (FIR) heat source is mounted 16.3, 18.3 in a position to be in front of a person seated in the seat portion 14, when the doors 16, 18 are closed. The FIR heat source is in the form of ceramic tiles which are electrically heated to a temperature ranging from ambient temperature to about 7O⁰C. The temperature is regulated by a temperature regulator (not shown).

A control panel 28, not shown in Figure 1 is part of a controller 30 which is operable to control the gas regulation means, the FIR heat sources 16.3, 18.3 and the Rife frequency delivery means 16.2, 18.2. In this embodiment, the electrical Rife frequency generator is integrated into the controller 30.

In Figure 2 the treatment device 10, is shown in use. A person 32, shown in broken lines is seated in the seat portion 14 of the chamber 12. The winged doors 16, 18 are closed and the person is holding the electrodes 16.2, 18.2.

The FIR heat sources 16.3, 18.3 are shown in position in front of the person.

In operation, the control box 30 is activated to turn on the heat sources 16.3, 18.3 and to release the O³ gas into the chamber 12.

The controller is then activated to generate electrical impulses and to deliver the electrical impulses to the hands of the person via the electrodes

16.2, 18.2.

This operation illustrates a method of applying beneficial stimuli to a body of a person 32 which includes providing a partially sealed chamber 12 around at least a portion of the body of the person and disposing O³ into the partially sealed chamber 12 so as to expose the portion of the body to an increased concentration of O³. The method further includes subjecting the portion of the body to a dry heat source in the form of the FIR heaters 16.3,

18.3, and subjecting the body of the person to a Rife frequency source via the electrodes 16.2, 18.2.

In Figure 3, the control panel 28 of the controller 30 is shown. The control panel 28 has a Liquid Crystal Display (LCD) screen 32 and four membrane buttons 34, 36, 38, 40. The button 38 selects a menu function and the buttons 34, 36 scrolls up or down respectively within a selected menu. Button 40 provides a start/stop function to activate/deactivate certain functions. Operation of the controller is summarized below:

1. Upon first activation for a particular day

1.1 the display 32 displays "InfraZone Mk 1.0";

1.2 the display 32 displays "System Check - Please Wait";

1.3 all components are checked indicidually and any errors are displayed in coded error messages;

1.4 if an error occurs the display 32 displays "Error - " and the error code;

1.5 if no errors were found the display 32 displays "InfraZone Mk1.0 - Ready";

1.6 a service interval messages is displayed which should be acknowledged by the operator;

1.7 if a service due date has past, the display 32 displays "Service due now - Unit in standby"

1.8 if operation can proceed, the display 32 displays "Time 30:00, Temp 40°"

2. The operator can now select a particular program:

2.1 if the menu button is pressed, the "Time", "Temp", "Mist", "Rife", "Service" selections are displayed sequentially.

By selecting the functions, the Time, Temperature, Mist setting and Rife function can be adjusted and set.

3. Once the system has been programmed, the display 32 displays "InfraZone MkLO - Ready". Upon pressing the start button 40, the programmed settings are displayed for five seconds before operation commences.

4. Two minutes before expiry of a session time, the O³ is evacuated from the chamber. The inventor believes the invention, as described and illustrated provides a new device for stress relief and applying beneficial stimuli to a body of a person and illustrates a new method of applying such beneficial stimuli.

The inventor believes that this device and method will provide enhanced treatment of persons to improve the overall wellness of a person in terms of medical applicability and to relief stress and reduce stress causing factors which are treatable with the technologies described.

Claims

CLAIMS:

1. A method of applying beneficial stimuli to a body of a person, the method including providing a partially sealed chamber around at least a portion of the body of a person and disposing a poly-atomic oxygen composition into the partially sealed chamber so as to expose the portion of the body to an increased concentration of the poly-atomic oxygen; subjecting the portion of the body to a dry heat source; and subjecting the potion of the body to a Rife frequency source.

2. A method as claimed in claim 1 , in which the poly-atomic oxygen composition is in the form of O³.

3. A method as claimed in claim 1 which includes spraying an atomized/nebulized liquid or mist onto the body of the person.

4. A method as claimed in claim 3, in which the atomized liquid is selected from any one of H₂O and H₂O₂.

5. A method as claimed in claim 1 , in which the Rife frequency source is in the form of any one of an electromagnetic wave generator, a pressure wave generator, an electro-magnetic coil and an electrical signal generator, all of which are operable to generate signals at the so called rife frequencies.

6. A method as claimed in claim 1 , which includes the prior step of positioning the body of a person in a position which is beneficial to lymphatic circulation and blood circulation.

7. A method as claimed in claim 5, in which the heat source is in the form of a Far Infra-Red (FIR) source.

8. A method as claimed in claim 7, in which the far infra-red source operates at a wavelength of between 2μm to 15μm.

9. A method as claimed in claim 1 in which subjecting the portion of the body to a dry heat source includes subjecting the portion of the body to a heat source of between 4O⁰C to 7O⁰C.

10. A method as claimed in claim 2, which includes subjecting at least aa ppoorrttiioonn ooff tthhee bbooddyy ooff aa ppeerrssoonn ttoo tthhee OO³³,, tthhee dry heat and the Rife frequencies for a period of between 10 and 60 minutes.

11. A method as claimed in claim 10 which includes subjecting at least a portion of the body of a person to the O³, the dry heat and the Rife frequencies for a period about 30 minutes.

12. A method as claimed in any one of claims 1 to 11 , which includes the latter step of extracting the Oxygen from the chamber.

13. A treatment device, which includes a chamber into which at least a portion of the body of a person can be positioned; heat generation means for heating the portion of the body of a person in the chamber;

14. A treatment device as claimed in claim 13, in which the chamber includes at least one gas port connectable to a supply of gas, the gas port extending into the chamber for release of gas into the chamber.

15. A treatment device as claimed in claim 14, which includes gas regulation means, in communication with the gas port and a supply of gas, the regulation means operable to control the flow of gas from the supply of gas, via the gas port into the chamber.

16. A treatment device as claimed in claim 15, which includes a controller, connectable to any one or more of the gas regulation means, the heat generation means and the Rife frequency delivery means, operable to control any one or more of the supply of gas via the gas regulation means, the heat generation means and the operation of the rife frequency generation means.

17. A treatment device as claimed in claim 13, in which the chamber is in the form of a sealed enclosure shaped and dimensioned to receive the whole of a person's body.

18. A treatment device as claimed in claim 17, in which the enclosure includes an aperture through which the head of a person may protrude, in use.

19. A treatment device as claimed in claim 18, in which the enclosure is shaped and dimensioned, in use, to receive a person in a seated position with an opening shaped and dimensioned to allow the neck of a person to protrude through it.

20. A treatment device as claimed in claim 13, in which the chamber is in the form of an enclosure, shaped and dimensioned to receive only a portion of a person's body.

21. A treatment device as claimed in claim 13, in which the device includes a second chamber shaped and dimensioned to receive a portion of a person's body, to define a zone of increased pressure, where the poly-atomic oxygen can be discharged on the skin of a person, in use.

22. A treatment device as claimed in claim 13, in which the heat generation means is disposed in the chamber, operable to generate heat in the chamber.

23. A treatment device as claimed in claim 13, in which the heat generation means is in the form of any one of an air heater, a resistive element type heater, and an Infra Red (IR) source.

24. A treatment device as claimed in claim 23, in which the heater includes electrically heatable ceramic tiles, operable to radiate a desired amount of Infra-Red radiation.

25. A treatment device as claimed in claim 23, in which the heat generation means includes a heat regulator, operable upon selection by a user to regulate the temperature in the chamber to a pre-selected temperature.

26. A treatment device as claimed in claim 13, in which the inside of the chamber is provided with reflective material, in use to promote even distribution of Infra-Red radiation.

27. A treatment device as claimed in claim 13, in which the Rife frequency delivery means is in the form of electro-magnetic coils disposed proximate a body of a user, when in use.

28. A treatment device as claimed in claim 27, which includes any one of a heart rate monitor and a heart rate monitor interface, operable to measure a heart rate of a person.

29. A treatment device as claimed in claim 13, in which the Rife frequency delivery means is in the form of electrical electrodes disposed in the chamber to be in contact with the body of a person.

30. A treatment device as claimed in claim 29, in which the electrodes are connectable to a heart rate monitor, operable when touched by a person to monitor the heart rate of the person.

31. A treatment device as claimed in claim 13, which includes a blood oxygen meter operable to monitor the blood oxygen level in a person's blood.

32. A treatment device as claimed in claim 13, which includes a toxin meter arranged to collect body fluids excreted through the skin of a person and to provide an indication of the composition of said fluids.

33. A method as claimed in claim 1 , substantially as herein described and illustrated.

34. A treatment device as claimed in claim 13, substantially as herein described and illustrated.

35. A new method and a new treatment device, substantially as herein described.